COMMUNIQUÉS West-GlobeNewswire

Syncromune Reports Long-Term Data from Phase 1 Study in Metastatic Prostate Cancer with Investigational SYNC-T Therapy SV-102
27/10/2026
Data support potential for highly differentiated clinical impact for patients suffering from metastatic prostate cancer 50% of patients who achieved a complete response (n=6) remain disease-free more than two years [...]
Nexalin Technology Announces Fourth Peer-Reviewed Publication in Alzheimer's Disease: 15 mA DIFS™ Significantly Improves Sleep Quality in Patients with Mild Alzheimer's Disease
27/10/2026
Results from the randomized, double-blind, sham-controlled TRANSFORM-AD study published in the Journal of Alzheimer's Disease, a recognized international peer-reviewed journal Statistically significant improvement in [...]
NorthStar Day Program, First of Its Kind in the Southeast, to Open in Palm Beach Gardens on November 4, 2026
27/10/2026
Innovative multidisciplinary program brings education, therapy, psychiatry and behavioral health services together under one roof for neurodivergent children ages 5–12 PALM BEACH GARDENS, Fla., Oct. 27, 2026 (GLOBE [...]
Pluri to Host Investor Conference Calls to Discuss Updates and Strategic Developments
27/10/2026
English-language call at 8:30 a.m. Eastern Time and Hebrew-language call at 11:00 a.m. Israel Time on Thursday, October 29, 2026 HAIFA, Israel, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq and TASE: PLUR) (“ [...]
Exagen to Announce Third Quarter Financial Results on November 10, 2026
27/10/2026
CARLSBAD, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended September 30, 2026, before the [...]
Emerging Digital Health Companies Choose HealthEx’s Platform and Health Records API to Personalize User Experiences with Clinical Context
27/10/2026
Companies in AI health coaching, rare disease care, caregiving, clinical trial matching and more build on the HealthEx health records API and MCP server to bring patients’ consented medical records from 90% of U.S. care [...]
aTyr Pharma Announces One-for-40 Reverse Stock Split
27/10/2026
aTyr’s common stock to begin trading on a post-split adjusted basis on October 29, 2026 SAN DIEGO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage [...]
The Gene Lay Institute of Immunology and Inflammation Expands World-Class Research Leadership, Appointing Four New Members
27/10/2026
Drs. Marco Colonna, Francisco J. Quintana, Howard L. Weiner, and Jun R. Huh join to advance clinical discovery in cross-system immunology. BOSTON, Oct. 27, 2026 (GLOBE NEWSWIRE) -- The Gene Lay Institute of Immunology [...]
Egetis Therapeutics Announces U.S. Launch of EMCITATE® for Patients with MCT8 Deficiency
27/10/2026
EMCITATE is the first and only FDA-approved treatment for peripheral thyrotoxicosis in adults and pediatric patients with MCT8 deficiency in the United States Egetis RareLink™, the dedicated patient support program, [...]
Coherus to Participate in Upcoming Investor Conferences
27/10/2026
REDWOOD CITY, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (NASDAQ: CHRS), today announced that the company will be webcasting its participation in the following upcoming investor conferences: [...]
Oncolytics Biotech® Reports Strong Durability and Survival Data in Anal Cancer, Positioning Pelareorep as Potential Backbone Immunotherapy Across HPV-Driven Cancers
27/10/2026
GOBLET Cohort 4 demonstrates approximately 15-month median duration of response that exceeds historical results for approved second-line checkpoint inhibitor monotherapy 100% of responding patients survived for longer [...]
Acentra Health Names Mihriban Brickner as Senior Vice President of Operations
27/10/2026
Experienced healthcare operations leader will drive company's key Integrated Health Solutions initiatives and support clients MCLEAN, Va., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Acentra Health , a technology and health [...]
Fort Collins Oral and Maxillofacial Surgeon Dr. Daetwyler Provides Free Dental Care in Cripple Creek
27/10/2026
FORT COLLINS, Colo. and CRIPPLE CREEK, Colo., Oct. 27, 2026 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management ( USOSM ) recognizes its surgeon partner Michael Daetwyler , DDS – as he completes medical mission work in [...]
Transactions in connection with share buy-back program
27/10/2026
Company announcement no. 43 - 26 27 October 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
Newsweek classe le KFSH parmi les 4 % d’hôpitaux les plus avancés au monde en matière de maturité numérique et d’IA
27/10/2026
RIYAD, Arabie saoudite, 27 oct. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSH) est l’un des 15 seuls hôpitaux au monde à avoir obtenu à la fois la note maximale de cinq rubans [...]
Immuron continued quarterly sales growth
27/10/2026
Sales Highlights (unaudited): Global Q1 sales AUD$2.2 million up 9% on prior comparative period (pcp) Q1 sales up 5% on prior quarter Australia Q1 sales AUD$1.8 million up 14% on prior comparative period (pcp) Q1 sales [...]
Nautilus Biotechnology Reports Third Quarter 2026 Financial Results
27/10/2026
SEATTLE, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third quarter ended [...]
Nautilus to Measure Proteoforms Driving Alzheimer’s Disease and Cancer in ARPA-H-Funded SEEDS Consortium
27/10/2026
Nautilus expects to receive up to $6 million to bring its Voyager™ Platform to a multidisciplinary team integrating protein science, AI, and computational modeling to develop new diagnostics and therapeutics SEATTLE, [...]
Aclaris Therapeutics Announces Positive Phase 1b Proof-of-Concept Primary Analysis Results for its Anti-TSLP/IL-4Rα Bispecific ATI-052 in Atopic Dermatitis (AD) and Asthma
27/10/2026
- Results Demonstrated Breadth and Rapidity of Response to ATI-052 in Heterogeneous Patient Populations; Pharmacodynamic Results Demonstrated Potential for Additivity/Synergy of Targeting TSLP and IL-4R α - - Rapid and [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum